The Lancet Oncology

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  

The Lancet Oncology
May 22, 2025, 08:26 | Blog
New Article in The Lancet Oncology: Global Roadmap for Cancer Care in Crisis by The Institute of Cancer and Crisis
The Institute of Cancer and Crisis (ICC) shared a post on LinkedIn about an article Raffaella…
May 21, 2025, 17:41 | Opinion
Bishal Gyawali addressed G7 cancer drug approval claims about Canada with the Lancet Oncology Study
Bishal Gyawali, Associate Professor at Queen’s University, shared a post on X about the article…
May 14, 2025, 06:59 | Science
Armando Orlandi: Prophylactic Surgeries Improve Survival in Young BRCA Carriers
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on LinkedIn:…
May 13, 2025, 07:25 | Science
Francisco Esteva: New Study Shows that BSO Markedly Reduces Cancer Risk in BRCA1/2 Carriers
Francisco Esteva, Director of the Breast Cancer Translational Research at Northwell Health and Chief of…
May 8, 2025, 09:59 | Insight
Elia Seguí: Can some early HER2+ BC be treated without chemotherapy
Elia Seguí, Predoctoral Researcher at Translational Genomics and Targeted therapies in Solid Tumors at August…
May 6, 2025, 10:31 | Science
Milos Grujic: First RCT comparing ENRT vs MDT in Oligorecurrent Nodal
Milos Grujic, Radiation Oncologist at the University Clinical Center Kragujevac, shared an article on X: "New…
May 6, 2025, 10:19 | Blog
EORTC Highlights Pragmatic Trials in New Lancet Oncology Publication
EORTC - European Organisation for Research and Treatment of Cancer posted on LinkedIn: "We’re thrilled…
May 6, 2025, 09:43 | Science
Piet Ost: MDT vs ENRT and MDT for Nodal Oligorecurrent Prostate Cancer
Piet Ost, Radiation Oncologist at Iridium Network Antwerp, shared an article on X: "STORM trial breaking…
May 6, 2025, 09:26 | Blog
Pierre Blanchard: Pelvic ENI for pelvic relapses after local treatment for Prostate Cancer
Pierre Blanchard, Radiation Oncologist at Gustave Roussy, shared a post on X: "STORM-PEACE V trial…
Apr 20, 2025, 08:16 | Science
Miloš Grujić: Which biopsy approach is better - LATP or TRUS?
Miloš Grujić, Radiation Oncologist at the University Clinical Center Kragujevac, shared an article by Richard J…
Apr 17, 2025, 08:24 | Insight
Highlights from an EU Medicines Agency-EORTC workshop - The Lancet Oncology
The Lancet Oncology shared a post on X: "Online first: highlights from an EU Medicines…
Apr 17, 2025, 07:21 | Blog
A joint European Medicines Agency–EORTC workshop
EORTC - European Organisation for Research and Treatment of Cancer posted on LinkedIn: "New Publication…
Apr 5, 2025, 05:54 | Blog
Wafik El-Deiry: Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
Wafik El-Deiry, Director of Legorreta Cancer Center at Brown University, posted on X: "The system…
Apr 5, 2025, 05:29 | Blog
David J. Benjamin: Sexual health and reproductive toxicity from cancer therapies
David J. Benjamin, Medical Oncologist at the Hoag Family Cancer Institute, shared an article on…
Apr 4, 2025, 11:28 | Science
Mark Lythgoe: Sexual health and reproductive toxicity from cancer therapies
Mark Lythgoe, Clinical Research Fellow in Medical Oncology at Imperial College London, shared an article…
Apr 4, 2025, 10:16 | Science
Neeraj Agarwal: Patient-reported QOL results in phase 3 TALAPRO-2 trial
Shilpa Gupta, Director of Genitourinary Oncology and a Professor of Medicine at Cleveland Clinic, reshared a…
Apr 3, 2025, 09:48 | Blog
Mark Lythgoe: Great to be editors pick in The Lancet Oncology this month
Mark Lythgoe, Clinical Research Fellow in Medical Oncology at Imperial College London, shared a post…
Apr 1, 2025, 12:34 | Blog
Asya Agulnik: Breakthrough approaches needed for pediatric cancer treatment in conflict-affected regions
Asya Agulnik, Associate Member of St. Jude Children’s Research Hospital Faculty, reshared a post by…
Mar 8, 2025, 06:20 | Blog
How the ATOM Coalition is tackling critical barriers to cancer treatment in LMICs - UICC
Union for International Cancer Control (UICC) posted on LinkedIn: "A commentary in The Lancet Oncology…
Mar 7, 2025, 08:45 | Blog
Amy Israel: Revolutionizing cancer medicine access in low- and middle-income countries
Amy Israel, Senior Advisor, Access to Medicines at Union for International Cancer Control, posted on…
Mar 6, 2025, 10:44 | Science
Adam B. Weiner: SBRT and ADT for oligometastatic prostate cancer
Adam B. Weiner,  Faculty at Cedars-Sinai Medical Center, shared an article by Giulia Marvaso, et…
Mar 6, 2025, 09:52 | Science
Gilberto Lopes: Revolutionising cancer treatment access LMICs
Gilberto Lopes, Medical Director for international programs and associate director at the Sylvester Comprehensive Cancer…
Mar 5, 2025, 08:32 | Blog
Giulia Marvaso: SBRT with and without ADT for hormone sensitive oligorecurrent prostate cancer
Giulia Marvaso, Assistant Professor at the University of Milan, posted on X about recent paper…
Mar 4, 2025, 05:25 | Science
Edward Christopher Dee: Cancer incidence and mortality estimates in 2022 in southeast Asia
Edward Christopher Dee, Resident Physician in Radiation Oncology at Memorial Sloan Kettering Cancer Center, shared…
Mar 1, 2025, 16:11 | Blog
Nirmala Bhoo Pathy: Comprehensive analysis of cancer incidence and mortality across Southeast Asia
Nirmala Bhoo Pathy, Professor of Epidemiology in the Department of Social and Preventive Medicine at…
Feb 19, 2025, 17:30 | Science
Carmine Valenza: Tailoring treatments in premenopausal patients with Breast Cancer
Carmine Valenza, Medical Oncology Resident at the European Institute of Oncology, shared an article by…
Feb 12, 2025, 06:20 | Science
Miguel Bronchud: Good news for the commonest clinical kidney cancer
Miguel Bronchud, Co-Founder & Advisory Board at Regenerative Medicine Solutions, shared an article on LinkedIn:…
Feb 6, 2025, 14:31 | Insight
Bishal Gyawali: A checklist to design and report cancer drug RCTs
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, shared a post on X about a…
Feb 6, 2025, 12:35 | Science
Bishal Gyawali: Celebrating World Cancer Day by pledging to improve the quality of our cancer RCTs
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, shared his recent article on X: "Let’s…
Feb 3, 2025, 08:17 | Blog
Bishal Gyawali: Our major publications from last 2 months
Bishal Gyawali, Associate Professor at Queen’s University, Kingston, posted on X: "These last 2 months…
Feb 1, 2025, 19:01 | Blog
Dégi László Csaba: Discussions on the future of cancer care at the World Economic Forum in 2025
Dégi László Csaba, President of the European Cancer Organisation, posted on LinkedIn: "LANCET ONCOLOGY NEWS.…
Feb 1, 2025, 07:22 | Blog
Amar Kishan: A link between acute and late toxicity following prostate radiotherapy
Amar Kishan, Radiation Oncologist, Professor, and Executive Vice Chair of Radiation Oncology at UCLA, shared…
Jan 25, 2025, 12:40 | Blog
Erman Akkus: Adding Tiragolumab to Atezolizumab-Bevacizumab in 1L HCC shows promising results
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post about recent paper by…
Jan 21, 2025, 15:29 | Science
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma
Stephen V Liu, Associate Professor of Medicine at Georgetown University, shared an article by Wan-Qin…
Jan 21, 2025, 06:17 | Insight
Fabio Moraes: Global linear accelerator requirements and personalised country recommendations
Fabio Moraes, Director of Global Oncology at Queen’s University, shared a post on X about…
Jan 14, 2025, 18:51 | Science
Abi Siva: Another step close to De-escalation
Abi Siva, Associate Professor and Director of Medical Oncology at MUSC Hollings Cancer Center, shared…
Jan 9, 2025, 15:48 | Blog
Michael Sapienza: Early-onset colorectal cancer incidence rates are rising in 27 of 50 countries/territories worldwide
Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance shared on LinkedIn: "A recent…
Jan 4, 2025, 15:35 | Science
Aris Angelis: The use of the ESMO MCBS for coverage and reimbursement decisions of cancer medicines
Aris Angelis, Secretary General for Strategic Planning at Greek Ministry of Health, shared a post…
Jan 4, 2025, 13:25 | Science
Abdul Rafeh Naqash: A state of the art review on pulmonary neuroendocrine neoplasms
Abdul Rafeh Naqash, Associate Professor and Director of Clinical Research at UT Southwestern Medical Center,…
Dec 25, 2024, 19:28 | Blog
The Lancet Oncology - Looking forward to working with our wonderful authors, reviewers, and readers in 2025
The Lancet Oncology shared on X- "Thank you to our wonderful authors, reviewers, and readers…
Dec 21, 2024, 05:42 | Insight
Raffaella Casolino: How to integrate cancer into crisis?
Raffaella Casolino, Technical Officer at the World Health Organization, shared a post on LinkedIn: “How…
Dec 20, 2024, 17:05 | Blog
UICC highlights progress in tackling cancer burden
Union for International Cancer Control (UICC) shared the following on LinkedIn: “The Union for International…
Dec 16, 2024, 16:39 | Science
Colorectal cancer incidence trends in younger versus older adults
An article was published on The Lancet Oncology by Hyuna Sung et al., titled "Colorectal…
Dec 16, 2024, 13:11 | Insight
Benedikt Westphalen: Rising colorectal cancer incidence in younger adults
Benedikt Westphalen, Medical Lead of Precision Oncology at CCC München – Comprehensive Cancer Center, shared…
Dec 13, 2024, 19:52 | Insight
Interim results from the EUROPA trial presented at SABCS24 - The Lancet Oncology
The Lancet Oncology shared a recent article on X: "Presented at SABCS24: Interim results from…
Nov 29, 2024, 16:04 | Blog
Cristiane D Bergerot: Insights to improve psychosocial care for patients with cancer
Cristiane D Bergerot, Director of the Department of Psycho-Oncology at CETTRO Cancer Research Hospital, shared…
Nov 26, 2024, 23:05 | Insight
A Comprehensive Analysis on the Rising Burden of Cancer in Adolescents and Young Adults
Ben Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, shared a…
Nov 13, 2024, 09:39 | Blog
AI tools to improve diagnosis and therapy in neuro-oncology
Pearl Freier, Founder of Cambridge BioPartners, shared a recent article by Javier E Villanueva-Meyer on…
Nov 12, 2024, 18:58 | Insight
Erman Akkus: First-line chemotherapies in advanced pancreatic cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post X: “First-line chemotherapies in…
Nov 12, 2024, 16:05 | Blog
A 2 part update on AI-RANO published on The Lancet Oncology
Vivek Subbiah posted on LinkedIn about recent paper by Javier E Villanueva-Meyer et al., titled "Artificial…
Nov 10, 2024, 04:24 | Blog
Empowering women oncologists in India - are we there yet?
Ophira Ginsburg, The Senior Scientific Officer and Senior Advisor for Clinical Research at the US…
Nov 8, 2024, 18:35 | Drugs
Do adjuvant aromatase inhibitors increase risk of ischaemic cardiotoxicity in postmenopausal patients with early breast cancer?
Erman Akkus shared a post on X: ''Do adjuvant aromatase inhibitors increase risk of ischaemic…
Nov 8, 2024, 06:58 | Insight
Elisa Agostinetto: Camizestrant vs Fulvestrant for estrogen receptor-positive, HER2-negative breast cancer
Elisa Agostinetto, Medical Research Fellow at the University Hospital of Brussels, shared an article by…
Nov 4, 2024, 13:32 | Insight
Paolo Tarantino: The SERENA-2 phase 2 trial of camizestrant vs fulvestrant is out
Paolo Tarantino, Research Fellow at The Dana-Farber Cancer Institute, shared on X: “The SERENA-2 phase…
Oct 30, 2024, 20:40 | Blog
Reassuring news for postmenopausal women undergoing treatment for early breast cancer - Danish Cancer Institute
Danish Cancer Institute posted on LinkedIn about recent paper by Marie Lund et al., titled…
Oct 20, 2024, 19:31 | Insight
Nirmala Bhoo Pathy: An inspiring meeting of the Lancet Oncology Commission on Human Crisis of Cancer
Nirmala Bhoo Pathy, Public health physician at the University Malaya Medical Centre, posted on LinkedIn:…
Oct 20, 2024, 18:54 | Insight
UCLA: New imaging technique accurately detects aggressive kidney cancer
UCLA investigators found the level of accuracy of the non-invasive method could lead to earlier…
Oct 18, 2024, 19:52 | Blog
Mariano Provencio: Perioperative chemotherapy and nivolumab in NSCLC
Mariano Provencio, Medical Oncology Chair at University Hospital Puerta de Hierro, shared on X: ''With…
Oct 16, 2024, 17:00 | Insight
Biagio Ricciuti: 5-year update from the NADIM trial
Biagio Ricciuti shared a post on X about a recent paper by Mariano Provencio et…
Oct 15, 2024, 12:59 | Blog
Brendon Stiles: We owe it to our patients with EGFR mutations
Brendon Stiles, Professor and Chief, Thoracic Surgery and Surgical Oncology, Montefiore Health System shared a post on…
Oct 7, 2024, 06:58 | Blog
Lancet Oncology Commission on radiotherapy and theranostics - The Lancet Oncology
John Christodouleas, GU Radiation Oncologist at PENN, shared a post by The Lancet Oncology on X, adding:…
Oct 4, 2024, 09:43 | Insight
Deridre Kelly: Ph2 Capmatinib in METex14 NSCLC
Deridre Kelly, Professor of Paediatric Hepatology at the University of Birmingham, sharen on X: "New…
Oct 1, 2024, 04:54 | Positive
Empowering Women in Oncology: LEAD 2024 Recognized Rana McKay and Nazli Dizman
Dr. Rana McKay and Dr. Nazli Dizman were honored at the LEAD 2024 The Leadership, Empowerment,…
Sep 30, 2024, 16:15 | Insight
Yakup Ergün: Rising costs of cancer medicines
Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared a post on X about a…
Sep 25, 2024, 14:15 | Career
Gilberto Lopes Is Running For The UICC Board of Directors
Gilberto Lopes is the medical director for international programs and associate director of the Sylvester…
Sep 23, 2024, 09:54 | Blog
Françoise Meunier: Belgium to Shorten Waiting Period for Cancer Survivors by 2025
Françoise Meunier posted the following on LinkedIn: “Starting January 2025, Belgium will shorten the waiting…
Sep 20, 2024, 12:32 | Blog
Mark Lawler: Financial discrimination against cancer survivors
Mark Lawler, Chair in Translational Cancer Genomics at Queen's University Belfast, shared a post on…
Sep 15, 2024, 12:48 | Insight
Shahrin Ahmed: The phase III trial was successful in the performance of the radiotracer for kidney cancer
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared a post on X: “The…
Sep 14, 2024, 15:33 | Insight
Zr-girentuximab for PET–CT imaging of clear-cell renal cell carcinoma
Toni Choueiri shared a post on X about a recent paper by Brian Shuch et…
Sep 13, 2024, 14:06 | Blog
Single fraction RT as an effective palliative treatment for painful liver cancer
David Kirsch, Radiation Oncologist at Princess Margaret Cancer Centre, shared on X: '' Congratulations Laura…
Sep 13, 2024, 07:51 | Blog
Neeraj Agarwal: Zr-girentuximab PET–CT for detecting ccRCC
Neeraj Agarwal shared a post on X, about recent paper published in The Lancet Oncology:…
Sep 11, 2024, 09:16 | Insight
Naveen Pemmaraju: Pivekimab sunirine in relapsed or refractory acute myeloid leukaemia
Naveen Pemmaraju shared a post on X about a recent paper by Naval Daver et…
Sep 5, 2024, 00:02 | Blog
Submit your clinical trials - ESTRO
European Society for Radiotherapy and Oncology shared a post on LinkedIn: “Radiotherapy & Oncology (the…
Sep 4, 2024, 11:18 | Insight
ESGO-ESHRE-ESGE guidelines for fertility-sparing treatment and follow-up in patients with cervical and ovarian cancer and borderline ovarian tumours
ESGO made the following post on X: "Published last night in The Lancet Oncology. Paper: ESGO-ESHRE-ESGE…
Sep 3, 2024, 13:56 | Blog
CReDO for early career cancer researcher
Pramesh CS, Director at Tata Memorial Hospital, shared a post on X: "If you are…
Aug 31, 2024, 14:46 | Insight
Philipp Karschnia: The oncological role of surgery in diffuse gliomas
Philipp Karschnia, Neurosurgery resident at  Ludwig-Maximilians-University of Munich, shared on X: "RANO review on the…
Aug 30, 2024, 10:39 | Insight
Article of the day, August 30th, suggested by the Immune Oncology Research Institute
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the day! Suggest by the Immune…
Aug 29, 2024, 15:39 | Insight
Belgium will shorten the waiting period for cancer survivors to exercise their 'right to be forgotten'
Françoise Meunier shared on LinkedIn: "Starting January 2025, Belgium will shorten the waiting period for…
Aug 26, 2024, 08:35 | Insight
Highlights from The California Cancer Consortium Conference 2024 by Sumanta K. Pal
The California Cancer Consortium Conference is an annual conference that brings together leading oncology experts,…
Aug 25, 2024, 19:31 | Blog
Mark Lawler: Time to defuse the ticking time bomb
Mark Lawler shared a post by The Lancet Oncology on X, adding: “Time to defuse…
Aug 23, 2024, 14:33 | Insight
Mark Lawler: Our Cancer in Conflict Manifesto
Mark Lawler shared on X: "Some month: Our Cancer in Conflict Manifesto in The Lancet.…
Aug 22, 2024, 03:27 | Blog
Mark Lawler: European Cancer Groundshot Research is a necessity, not a luxury
Mark Lawler shared a post by Irish Cancer Society on X, adding: “Remember our often…
Aug 21, 2024, 14:16 | Blog
EORTC - Understanding long-term quality of life after completion of an adjuvant treatment for melanoma
EORTC - European Organisation for Research and Treatment of Cancer shared on LinkedIn: " Have you…
Aug 12, 2024, 07:42 | Blog
Ursula Sansom-Daly: An honour to join The Lancet Oncology AYA Cancer Commission
Ursula Sansom-Daly, Senior Research Fellow at UNSW Faculty of Medicine and Health, shared a post…
Aug 9, 2024, 02:21 | Insight
Paolo Tarantino: Interesting sub analysis from the SENOMAC trial
Paolo Tarantino shared on X about a recent paper by Jana de Boniface et al.…
Aug 6, 2024, 02:02 | Insight
Trastuzumab deruxtecan therapy in patients with HER2-positive metastatic breast cancer
Francisco Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
Aug 4, 2024, 11:57 | Blog
Mark Lawler: We call out for greater emphasis and investment in Lung Cancer Research
Mark Lawler shared a post by Lung Cancer Europe on X, adding: “Lung cancer. 21%…
Jul 31, 2024, 10:58 | Insight
Yüksel Ürün: PSMA-PET by PROMISE effective in high/low-risk stratification in prostate cancer
Yüksel Ürün shared on X about a recent paper titled "Combining PSMA-PET and PROMISE to re-define…
Jul 25, 2024, 08:10 | Blog
Giannis Mountzios: A very useful prognostic tool for patients under IO
Giannis Mountzios, Medical Oncologist at the Department of Medical Oncology in the Air Force General…
Jul 13, 2024, 15:19 | Blog
Kristina Jenei: Are countries harmonizing up or down?
Dario Trapani, Medical Oncologist at European Institute of Oncology, shared a post by Kristina Jenei, Associate…
Jul 10, 2024, 12:55 | Blog
Elisa Agostinetto: 10 key pressure points in the delivery of cancer care that need to be urgently addressed
Elisa Agostinetto shared a policy review by Ajay Aggarwal on X, adding the following: “Out…
Jun 24, 2024, 03:22 | Insight
Deniz Can Guven: The OS benefits of cancer drugs approved by surrogate endpoints
Deniz Can Guven, The Editorial Board Member in BMC Cancer, shared on X: "Out in…
Jun 21, 2024, 09:25 | Blog
Thank you Lancet Oncology for the shout out in the latest editorial - Common Sense Oncology
Common Sense Oncology posted on X: "Thank you The Lancet Oncology for the shout out…
Jun 16, 2024, 19:51 | Blog
Mark Lawler: Consistency of cancer policy is associated with better outcomes
Mark Lawler shared a post by Dr. Liz O'Riordan on X/Twitter: "Have been banging this…
Jun 3, 2024, 16:05 | Blog
Yehoda Martei: Female powerhouse presenting at the The Lancet Oncology commission on women, power and cancer
Yehoda Martei, Assistant Professor of Hematology-Oncology at the Hospital of the University of Pennsylvania, shared a…
May 14, 2024, 16:28 | Blog
Christian Rolfo: Great editorial by Ticiana Batista and Suresh S. Ramalingam on 20 years of EGFR
Christian Rolfo, Associate Director Clinical Research Center of Thoracic Oncology at The Tisch Cancer Institute…
May 5, 2024, 07:48 | Blog
Timothée Olivier: The regulatory failure of sotorasib in lung!
Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals shared a thread on X:…
Apr 17, 2024, 17:30 | Blog
The results of the meeting of the Advisory Group to Recommend Priorities for the IARC Monographs 2025–2029 - IARC
IARC shared a post on X/Twitter: "The results of the meeting of the Advisory Group to…
Apr 14, 2024, 04:22 | Blog
Vincent Rajkumar: Of all my tweets on taking care of patients, here are 3 personal favorites
Vincent Rajkumar, Editor-in-Chief of Blood Cancer Journal, shared on X/Twitter: "Of all my tweets on…
Apr 13, 2024, 09:52 | Drugs
Matt Campbell: The results of *two* Phase 2 studies of cabozantinib in Adrenal Cancer in The Lancet Oncology
Matt Campbell, Genitorurinary medical oncologist at UT MD Anderson Cancer center, shared a post on X:…
12
All: 128 Posts: 1 - 100
Special Coverage